Legal Representation
Attorney
Cynthia Johnson Walden
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 15, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 15, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 12, 2023 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Dec 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 8, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 11, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Dec 8, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Dec 8, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Dec 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 10, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 8, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 8, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 8, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 8, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 8, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 16, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 15, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 8, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 15, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 8, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 8, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 8, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 8, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 8, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 8, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 8, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 8, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 8, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 10, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 10, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 20, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 20, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 20, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 16, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 16, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 16, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients
Additional Information
Translation
The English translation of "ELEVAR" in the mark is "to raise".
Classification
International Classes
005